litlas
Log inCreate account

Gianpietro Dotti

Active 1999–2026

170
Papers
34,072
Citations
95
h-index
165
i10-index

Citations

Citations per year for Gianpietro Dotti1975: 1 citations1996: 1 citations1999: 3 citations2000: 5 citations2001: 17 citations2002: 23 citations2003: 25 citations2004: 29 citations2005: 32 citations2006: 43 citations2007: 41 citations2008: 43 citations2009: 102 citations2010: 146 citations2011: 173 citations2012: 161 citations2013: 297 citations2014: 231 citations2015: 341 citations2016: 384 citations2017: 501 citations2018: 685 citations2019: 1,528 citations2020: 2,000 citations2021: 2,076 citations2022: 2,002 citations2023: 1,723 citations2024: 2,505 citations2025: 1,511 citations2026: 41 citations1976–1995: no citations, so these years are not shown1997–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,699 citing papers, 28.3% of this breakdownChina: 3,270 citing papers, 25.1% of this breakdownGermany: 721 citing papers, 5.5% of this breakdownItaly: 524 citing papers, 4% of this breakdownUnited Kingdom: 503 citing papers, 3.9% of this breakdownFrance: 332 citing papers, 2.5% of this breakdownAustralia: 254 citing papers, 2% of this breakdownCanada: 247 citing papers, 1.9% of this breakdownJapan: 238 citing papers, 1.8% of this breakdownIran: 236 citing papers, 1.8% of this breakdownSpain: 235 citing papers, 1.8% of this breakdownNetherlands: 226 citing papers, 1.7% of this breakdown
0%28.3%Other 19.7%

Institutions

Fields

  • Medicine63%
  • Immunology and Microbiology12.8%
  • Biochemistry, Genetics and Molecular Biology11.8%
  • Engineering7.5%
  • Pharmacology, Toxicology and Pharmaceutics1.9%
  • Materials Science1.8%
  • Other1.2%

Topics

  • CAR-T cell therapy research18.2%
  • Immunotherapy and Immune Responses7.2%
  • Immune Cell Function and Interaction6.8%
  • Virus-based gene therapy research5.6%
  • Nanoplatforms for cancer theranostics4.1%
  • Cancer Immunotherapy and Biomarkers3.8%
  • Other54.3%

Coauthors

All papers

Open in search
  1. Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours

    Authors: Christian Flugel, Robbie G. Majzner, Giedre Krenciute, Gianpietro Dotti, Stanley R. Riddell, Dimitrios L. Wagner, Mohamed Abou‐El‐Enein - Nature Reviews Clinical Oncology 2022 cited by 508

  2. In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment

    Authors: Qian Chen, Chao Wang, Xudong Zhang, Guojun Chen, Quanyin Hu, Hongjun Li, Jinqiang Wang, Di Wen, Yuqi Zhang, Yifei Lü, Guang Yang, Chen Jiang, Jun Wang, Gianpietro Dotti, Zhen Gu - Nature Nanotechnology 2018 cited by 1,016

  3. HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma

    Authors: Nabil Ahmed, Vita S. Brawley, Meenakshi Hegde, Kevin Bielamowicz, Mamta Kalra, Daniel Landi, Catherine Robertson, Tara Gray, Oumar Diouf, Amanda Wakefield, Alexia Ghazi, Claudia Gerken, Zhongzhen Yi, Aidin Ashoori, Meng-Fen Wu, Hao Liu, Cliona M. Rooney, Gianpietro Dotti, Adrian P. Gee, Jack Su, Yvonne Kew, David S. Baskin, Yi Jonathan Zhang, Pamela New, Bambi Grilley, Milica Stojakovic, John Hicks, Suzanne Z. Powell, Malcolm K. Brenner, Helen E. Heslop, Robert G. Grossman, Winfried S. Wels, Stephen Gottschalk - JAMA Oncology 2017 cited by 837

  4. Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets

    Authors: Quanyin Hu, Hongjun Li, Edikan Archibong, Qian Chen, Huitong Ruan, Sarah Ahn, Elena Dukhovlinova, Yang Kang, Di Wen, Gianpietro Dotti, Zhen Gu - Nature Biomedical Engineering 2021 cited by 371

  5. Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15

    Authors: Yang Xu, Ming Zhang, Carlos A. Ramos, April Durett, Enli Liu, Olga Dakhova, Hao Liu, Chad J. Creighton, Adrian P. Gee, Helen E. Heslop, Cliona M. Rooney, Barbara Savoldo, Gianpietro Dotti - Blood 2014 cited by 736

  6. Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy

    Authors: Antonio Di Stasi, Siok‐Keen Tey, Gianpietro Dotti, Yuriko Fujita, Alana A. Kennedy‐Nasser, Caridad Martinez, Karin Straathof, Enli Liu, April Durett, Bambi Grilley, Hao Liu, Carolina Colli Cruz, Barbara Savoldo, Adrian P. Gee, John Schindler, Robert A. Krance, Helen E. Heslop, David M. Spencer, Cliona M. Rooney, Malcolm K. Brenner - New England Journal of Medicine 2011 cited by 1,495

  7. Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

    Authors: Nabil Ahmed, Vita S. Brawley, Meenakshi Hegde, Catherine Robertson, Alexia Ghazi, Claudia Gerken, Enli Liu, Olga Dakhova, Aidin Ashoori, Amanda Corder, Tara Gray, Meng-Fen Wu, Hao Liu, John Hicks, Nino Rainusso, Gianpietro Dotti, Zhuyong Mei, Bambi Grilley, Adrian P. Gee, Cliona M. Rooney, Malcolm K. Brenner, Helen E. Heslop, Winfried S. Wels, Lisa L. Wang, Peter M. Anderson, Stephen Gottschalk - Journal of Clinical Oncology 2015 cited by 979

  8. CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma

    Authors: Andras Heczey, Chrystal U. Louis, Barbara Savoldo, Olga Dakhova, April Durett, Bambi Grilley, Hao Liu, Mengfeng F. Wu, Zhuyong Mei, Adrian P. Gee, Birju Mehta, Huimin Zhang, Nadia Mahmood, Haruko Tashiro, Helen E. Heslop, Gianpietro Dotti, Cliona M. Rooney, Malcolm K. Brenner - Molecular Therapy 2017 cited by 530

  9. Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results

    Authors: Andras Heczey, Xin Xu, Amy N. Courtney, Gengwen Tian, Gabriel A. Barragán, Linjie Guo, Claudia Martínez-Amador, Nisha Ghatwai, Purva Rathi, Michael S. Wood, Yanchuan Li, Chunchao Zhang, Thorsten Demberg, Erica J. Di Pierro, Andrew C. Sher, Huimin Zhang, Birju Mehta, Sachin G. Thakkar, Bambi Grilley, Tao Wang, Brian Weiss, Antonino Montalbano, Meena Subramaniam, Chenling Xu, Chirag Sachar, Daniel K. Wells, Gianpietro Dotti, Leonid S. Metelitsa - Nature Medicine 2023 cited by 189

  10. Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape

    Authors: Meenakshi Hegde, Malini Mukherjee, Zakaria Grada, Antonella Pignata, Daniel Landi, Shoba A. Navai, Amanda Wakefield, Kristen Fousek, Kevin Bielamowicz, Kevin Chow, Vita S. Brawley, Tiara T. Byrd, Simone Krebs, Stephen Gottschalk, Winfried S. Wels, Matthew L. Baker, Gianpietro Dotti, Maksim Mamonkin, Malcolm K. Brenner, Jordan S. Orange, Nabil Ahmed - Journal of Clinical Investigation 2016 cited by 672

  11. Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma

    Authors: Chrystal U. Louis, Barbara Savoldo, Gianpietro Dotti, Martin Pulé, Eric Yvon, Gary D. Myers, Claudia Rössig, Heidi V. Russell, Oumar Diouf, Enli Liu, Hao Liu, Meng-Fen Wu, Adrian P. Gee, Zhuyong Mei, Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner - Blood 2011 cited by 1,171

  12. In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy

    Authors: Chao Wang, Jinqiang Wang, Xudong Zhang, Shuangjiang Yu, Di Wen, Quanyin Hu, Yanqi Ye, Hunter N. Bomba, Xiuli Hu, Zhuang Liu, Gianpietro Dotti, Zhen Gu - Science Translational Medicine 2018 cited by 579

  13. Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells

    Authors: Pritha Agarwalla, Edikan A. Ogunnaike, Sarah Ahn, Kristen Froehlich, Anton Jansson, Frances S. Ligler, Gianpietro Dotti, Yevgeny Brudno - Nature Biotechnology 2022 cited by 192

  14. Dual-targeting CAR-T cells with optimal co-stimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors

    Authors: Koichi Hirabayashi, Hongwei Du, Yang Xu, Peishun Shou, Xin Zhou, Giovanni Fucà, Elisa Landoni, Chuang Sun, Yu‐Hui Chen, Barbara Savoldo, Gianpietro Dotti - Nature Cancer 2021 cited by 209

  15. STING agonist promotes CAR T cell trafficking and persistence in breast cancer

    Authors: Nuo Xu, Douglas C. Palmer, Alexander C. Robeson, Peishun Shou, Hemamalini Bommiasamy, Sonia J. Laurie, Caryn Willis, Gianpietro Dotti, Benjamin G. Vincent, Nicholas P. Restifo, Jonathan S. Serody - The Journal of Experimental Medicine 2020 cited by 188

  16. Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis

    Authors: Andras Heczey, Amy N. Courtney, Antonino Montalbano, Simon N. Robinson, Liu Ka, Mingmei Li, Nisha Ghatwai, Olga Dakhova, Bin Liu, Tali Raveh-Sadka, Cynthia Chauvin, Xin Xu, Ho Ngai, Erica J. Di Pierro, Barbara Savoldo, Gianpietro Dotti, Leonid S. Metelitsa - Nature Medicine 2020 cited by 276

  17. Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers

    Authors: Pavel Sumazin, Andras Heczey, John M. Maris, Antonino Montalbano, Amy N. Courtney, Jennifer Pogoriler, Sachin G. Thakkar, Gianpietro Dotti, David Steffin, Premal Lulla, Natalia Lapteva, Dolores López‐Terrada, Zhuyong Mei, Carlos A. Ramos, Malcolm K. Brenner, Ramy Sweidan, Stephen Gottschalk, Huimin Zhang, Nisha Ghatwai, Navin Varadarajan, Leonid S. Metelitsa, Kalyani Patel, Helen E. Heslop, Azlann Arnett, Prakash Masand, Tao Wang, Tannaz Armaghany, Julien Fleurence, Purva Rathi, Bambi Grilley, Daniel Martínez, Deborah Lyon - Nature 2024 cited by 207

  18. An inducible caspase 9 safety switch for T-cell therapy

    Authors: Karin Straathof, Martin Pulé, Patricia Yotnda, Gianpietro Dotti, Elio F. Vanin, Malcolm K. Brenner, Helen E. Heslop, David M. Spencer, Cliona M. Rooney - Blood 2005 cited by 741

  19. Catch me if you can: how AML and its niche escape immunotherapy

    Authors: Sarah Tettamanti, Alice Pievani, Andrea Biondi, Gianpietro Dotti, Marta Serafini - Leukemia 2021 cited by 206

  20. Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

    Authors: Martin Pulé, Barbara Savoldo, Gary D. Myers, Claudia Rössig, Heidi V. Russell, Gianpietro Dotti, M. Helen Huls, Enli Liu, Adrian P. Gee, Zhuyong Mei, Éric Yvon, Heidi L. Weiss, Hao Liu, Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner - Nature Medicine 2008 cited by 1,190

  21. Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma

    Authors: Carlos A. Ramos, Natalie S. Grover, Anne Beaven, Premal Lulla, Meng-Fen Wu, Anastasia Ivanova, Tao Wang, Thomas C. Shea, Cliona M. Rooney, Christopher Dittus, Steven I. Park, Adrian P. Gee, Paul W. Eldridge, Kathryn McKay, Birju Mehta, Catherine Cheng, Faith Brianne Buchanan, Bambi Grilley, Kaitlin Morrison, Malcolm K. Brenner, Jonathan S. Serody, Gianpietro Dotti, Helen E. Heslop, Barbara Savoldo - Journal of Clinical Oncology 2020 cited by 380

  22. In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas

    Authors: Carlos A. Ramos, Rayne H. Rouce, Catherine Robertson, A. Reyna, Neeharika Narala, Gayatri Vyas, Birju Mehta, Huimin Zhang, Olga Dakhova, George Carrum, Rammurti T. Kamble, Adrian P. Gee, Zhuyong Mei, Meng-Fen Wu, Hao Liu, Bambi Grilley, Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner, Barbara Savoldo, Gianpietro Dotti - Molecular Therapy 2018 cited by 293

  23. Cryo-shocked cancer cells for targeted drug delivery and vaccination

    Authors: Tianyuan Ci, Hongjun Li, Guojun Chen, Zejun Wang, Jinqiang Wang, Peter Abdou, Yiming Tu, Gianpietro Dotti, Zhen Gu - Science Advances 2020 cited by 187

  24. Interleukin-23 engineering improves CAR T cell function in solid tumors

    Authors: Xingcong Ma, Peishun Shou, Christof C. Smith, Yu‐Hui Chen, Hongwei Du, Chuang Sun, Nancy P. Kren, Daniel Michaud, Sarah Ahn, Benjamin G. Vincent, Barbara Savoldo, Yuliya Pylayeva‐Gupta, Shuqun Zhang, Gianpietro Dotti, Yang Xu - Nature Biotechnology 2020 cited by 243